Contact Us

Congratulations: Beilu Pharma's Iohexol Injection Passed the Consistency Evaluation for Generic Drugs

2021/04/21

Table of Content [Hide]



    Iohexol Contrast


    Recently, Beijing Beilu Pharmaceutical Co., Ltd received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration (NMPA) on Iohexol Injection (100ml:35g, 100ml:30g), and the company's iohexol contrast passed the quality and efficacy consistency evaluation for generic drugs!


    References
    Related Products
    Related News